The criteria for Wegovy are BMI over 30 or BMI over 27 PLUS weight-related comorbidities, such as elevated cholesterol and/or triglycerides, high blood pressure, sleep apnea, etc
9 Zepbound (terzepatide) is also injected subcutaneously once weekly at a recommended dosage of 5 to 15 mg
On-going communication with the healthcare providers, such as primary care physicians where necessary, is promoted to follow-up complete care
Likewise, the safety profile of all Semaglutide-based medicines remains similar
Always check with your doctor before beginning any new medications or workouts.
Their accumulation due to impaired kidney function triggers systemic inflammation, which worsens as CKD progresses